Skip to menu Skip to content Skip to footer

2003

Journal Article

Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3

Barbour, A. P., Reeder, J. A., Walsh, M. D., Fawcett, J., Antalis, T. M. and Gotley, D. C. (2003). Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3. Cancer Research, 63 (4), 887-892.

Expression of the CD44v2-10 isoform confers a metastatic phenotype: Importance of the heparan sulfate attachment site CD44v3

2000

Conference Publication

Glycosaminoglycan-modified CD44v3 confers a metastatic phenotype on a human hepatocellular carcinoma (HCC) cell line in a murine model

Barbour, A., Reeder, J., Fawcett, J., Walsh, M., Antalis, T. M. and Gotley, D. C. (2000). Glycosaminoglycan-modified CD44v3 confers a metastatic phenotype on a human hepatocellular carcinoma (HCC) cell line in a murine model. 91st Annual Meeting of American Association for Cancer Research, San Francisco, 1-5 Apr, 2000. Philadelphia, U.S.A.: American Association for Cancer Research.

Glycosaminoglycan-modified CD44v3 confers a metastatic phenotype on a human hepatocellular carcinoma (HCC) cell line in a murine model